Arca Biopharma reported $4.09M in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Arca Biopharma USD 4.09M 441K Mar/2025
Biogen USD 37.9M 700K Mar/2026
Compugen USD 954K 116K Sep/2025
CSL USD 18M 1000K Dec/2024
Cytokinetics USD 11.02M 448K Mar/2026
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Myriad Genetics USD 300K 0 Mar/2025
Otsuka Holdings JPY 10.49B 396M Jun/2024
Pfizer USD 115M 51M Mar/2026
United Therapeutics USD 43.2M 3.2M Dec/2025